{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:01:06Z","timestamp":1791216066006,"version":"4.1.0"},"publisher-location":"Vienna","reference-count":191,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211832752","type":"print"},{"value":"9783709163603","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-3-7091-6360-3_1","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T01:06:34Z","timestamp":1349485594000},"page":"1-29","source":"Crossref","is-referenced-by-count":248,"title":["Post mortem studies in Parkinson\u2019s disease \u2014 is it possible to detect brain areas for specific symptoms?"],"prefix":"10.1007","author":[{"given":"K. A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","first-page":"166","volume-title":"Movement disorders 2","author":"Y Agid","year":"1987","unstructured":"Agid Y, Javoy-Agid F, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson\u2019s disease. In: Marsden CD, Fahn ST (eds) Movement disorders 2. Butterworth, London, pp 166\u2013230"},{"key":"1_CR2","first-page":"83","volume":"53","author":"Y Agid","year":"1990","unstructured":"Agid Y, Graybiel AM, Ruberg M et al (1990) The efficacy of levodopa treatment declines in the course of Parkinson\u2019s disease. Do non-dopaminergic lesions play a role? Adv Neurol 53: 83\u2013100","journal-title":"Adv Neurol"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/1353-8020(95)00011-T","volume":"1","author":"RL Albin","year":"1995","unstructured":"Albin RL (1995) The pathophysiology of chorea, ballism and parkinsonism. Parkinsonism Rel Disord 1: 2\u2013133","journal-title":"Parkinsonism Rel Disord"},{"key":"1_CR4","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F et al (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12: 25\u201331","journal-title":"Histol Histopathol"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.51.3.803","volume":"51","author":"A Antonini","year":"1998","unstructured":"Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D (1998) The metabolic anatomy of tremor in Parkinson\u2019s disease. Neurology 51: 803\u2013810","journal-title":"Neurology"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s004010050917","volume":"96","author":"K Arima","year":"1998","unstructured":"Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Ueahra H, Kawai M (1998) NACP\/\u03b1-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 96: 439\u2013444","journal-title":"Acta Neuropathol"},{"key":"1_CR7","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, et al. (1998) Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152: 879\u2013884","journal-title":"Am J Pathol"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-4613-0485-2_33","volume":"41","author":"T Bagmen","year":"1994","unstructured":"Bagmen T, Carmine B, De-Long MR (1994) Parkinsonian tremor is associated with low frequency oscillations in selective loops of the basal ganglia. Adv Behav Biol 41: 317\u2013325","journal-title":"Adv Behav Biol"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.870130205","volume":"13","author":"RB Banati","year":"1998","unstructured":"Banati RB, Daniel SE, Path MRC, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson\u2019s disease. Mov Disord 13: 221\u2013227","journal-title":"Mov Disord"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3171\/jns.1996.84.2.0203","volume":"84","author":"AL Benabid","year":"1996","unstructured":"Benabid AL, Pollak P, Gao DM et al (1996) Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 84: 203\u2013214","journal-title":"J Neurosurg"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/brain\/103.1.23","volume":"103","author":"MB Bender","year":"1980","unstructured":"Bender MB (1980) Brain control of conjugate horizontal and vertical eye movements. Brain 103: 25\u201369","journal-title":"Brain"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O et al (1973) Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415\u2013455","journal-title":"J Neurol Sci"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02740748","volume":"12","author":"F Blandini","year":"1996","unstructured":"Blandini F, Porter RHP, Greenamyre JT (1996) Glutamate and Parkinson\u2019s disease. Mol Neurobiol 12: 73\u201394","journal-title":"Mol Neurobiol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ana.410410118","volume":"41","author":"H Boecker","year":"1997","unstructured":"Boecker H, Wills AJ, Ceballos-Baumann A et al (1997) Stereotactic thalamotomy in tremor-dominant Parkinson\u2019s disease \u2014 An (H2O)-O-15 PET motor activation study. Ann Neurol 41: 108\u2013111","journal-title":"Ann Neurol"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ et al (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62: 133\u2013140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/BF01276421","volume":"103","author":"H Braak","year":"1996","unstructured":"Braak H, Braak E, Yilmazer D et al (1996) Pattern of brain destruction in Parkinson\u2019s and Alzheimer\u2019s diseases. J Neural Transm 103: 455\u2013490","journal-title":"J Neural Transm"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(93)90061-3","volume":"115","author":"DJ Brooks","year":"1993","unstructured":"Brooks DJ (1993) Functional imaging in relation to parkinsonian syndromes. J Neurol Sci 115: 1\u201317","journal-title":"J Neurol Sci"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410410108","volume":"41","author":"SF Bucher","year":"1997","unstructured":"Bucher SF, Seelos KC, Dodel RC et al (1997) Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol 41: 32\u201340","journal-title":"Ann Neurol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1471-4159.1998.71020517.x","volume":"71","author":"RE Burke","year":"1998","unstructured":"Burke RE, Antonelli M, Sulzer D (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71: 517\u2013525","journal-title":"J Neurochem"},{"key":"1_CR20","first-page":"254","volume":"319","author":"SW Carmichael","year":"1988","unstructured":"Carmichael SW, Wilson RJ, Brimijoin WS et al (1988) Decreased catecholamines in the adrenal medulla of patients with parkinsonism. N Engl Med J 319: 254","journal-title":"N Engl Med J"},{"key":"1_CR21","first-page":"438","volume":"60","author":"V Chan-Palay","year":"1993","unstructured":"Chan-Palay V (1993) Depression and dementia in Parkinson\u2019s disease: Catecholaminergic changes in the locus ceruleus. A basis for therapy. Adv Neurol 60: 438\u2013446","journal-title":"Adv Neurol"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0022-510X(95)00033-X","volume":"130","author":"MH Chang","year":"1995","unstructured":"Chang MH, Chang TW, Lai PH, Sy CG (1995) Resting tremor only \u2014 a variant of Parkinson\u2019s disease or of essential tremor. J Neurol Sci 130: 215\u2013219","journal-title":"J Neurol Sci"},{"issue":"2","key":"1_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1212\/WNL.51.2_Suppl_2.S30","volume":"51","author":"TN Chase","year":"1998","unstructured":"Chase TN, Oh JD, Blanchet PJ (1998) Neostriatal mechanisms in Parkinson\u2019s disease. Neurology 51(2) [Suppl 2]: 30\u201335","journal-title":"Neurology"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0306-4522(89)90239-X","volume":"28","author":"SK Coles","year":"1989","unstructured":"Coles SK, Iies JF, Nicolopoulos-Stournaras S (1989) The mesencephalic centre controlling locomotion in the rat. Neuroscience 28: 149\u2013157","journal-title":"Neuroscience"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jnnp.65.2.164","volume":"65","author":"TJ Counihan","year":"1998","unstructured":"Counihan TJ, Penney JB, Jr (1998) Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson\u2019s diseased brains. J Neurol Neurosurg Psychiatry 65: 164\u2013169","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF00310030","volume":"83","author":"GE Dale","year":"1992","unstructured":"Dale GE, Probst A, Luthert P, et al (1992) Relationship between Lewy bodies and pale bodies in Parkinson\u2019s disease. Acta Neuropathol 83: 525\u2013529","journal-title":"Acta Neuropathol"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"A442","DOI":"10.1212\/WNL.46.5.1262","volume":"46","author":"P Damier","year":"1996","unstructured":"Damier P, Hirsch EC, Agid Y (1996) Patterns of cell loss in the substantia nigra in Parkinson\u2019s disease. Neurology 46: A442","journal-title":"Neurology"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1749-6632.1988.tb42095.x","volume":"537","author":"AY Deutch","year":"1988","unstructured":"Deutch AY, Goldstein M, Baldino FJ, Roth RH (1988) Telencephalic projections of the A8 dopaminergic cell group. Ann NY Acad Sci 537: 27\u201350","journal-title":"Ann NY Acad Sci"},{"key":"1_CR29","first-page":"1093","volume":"18","author":"D Dormont","year":"1997","unstructured":"Dormont D, Cornu P, Pidoux B et al (1997) Chronic thalamic stimulation with three-dimensional MR stereotactic guidance. Am J Neuroradiol 18: 1093\u20131107","journal-title":"Am J Neuroradiol"},{"key":"1_CR30","first-page":"763","volume":"150","author":"B Dubois","year":"1994","unstructured":"Dubois B, Malapani C, Verin M et al (1994) Cognitive functions and the basal ganglia. The model of Parkinson\u2019s disease. Rev Neurol 150: 763\u2013770","journal-title":"The model of Parkinson\u2019s disease. Rev Neurol"},{"key":"1_CR31","first-page":"447","volume":"60","author":"C Duyckaerts","year":"1993","unstructured":"Duyckaerts C, Gaspar P, Costa C et al (1993) Dementia in Parkinson\u2019s disease. Morphometric data. Adv Neurol 60: 447\u2013455","journal-title":"Morphometric data. Adv Neurol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/86.4.781","volume":"86","author":"MJ Eadie","year":"1963","unstructured":"Eadie MJ (1963) The pathology of certain medullary nuclei in parkinsonism. Brain 86: 781\u2013795","journal-title":"Brain"},{"key":"1_CR33","first-page":"223","volume-title":"Dopamine autoreceptor pharmacology and function: Recent insights","author":"J Elsworth","year":"1996","unstructured":"Elsworth J, Roth R (1996) Dopamine autoreceptor pharmacology and function: Recent insights. In: Neve K, Neve R (eds) The dopamine receptors. Humana Press, Totowa, NJ, pp 223\u2013265"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-328X(97)00172-1","volume":"50","author":"DJ Eve","year":"1997","unstructured":"Eve DJ, Nisbet AP, Kingsburg AE et al (1997) Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson\u2019s disease. Mol Brain Res 50: 59\u201370","journal-title":"Mol Brain Res"},{"key":"1_CR35","first-page":"545","volume-title":"Neurodegenerative diseases","author":"JM Fearnley","year":"1994","unstructured":"Fearnley JM, Lees AJ (1994) Pathology of Parkinson\u2019s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545\u2013554"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/brain\/119.3.823","volume":"119","author":"A Fernandez","year":"1996","unstructured":"Fernandez A, Deceballos ML, Rose S et al (1996) Alterations in peptide levels in Parkinson\u2019s disease and incidental Lewy body disease. Brain 119: 823\u2013830","journal-title":"Brain"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/01616412.1997.11740768","volume":"19","author":"PM Fernandez","year":"1997","unstructured":"Fernandez PM, Dujovny M (1997) Pallidotomy \u2014 Editorial review. Neurol Res 19: 25\u201334","journal-title":"Neurol Res"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0022-510X(91)90169-8","volume":"103","author":"Y Furukawa","year":"1991","unstructured":"Furukawa Y, Kondo T, Nishi K et al (1991) Total biopterin levels in the ventricular CSF of patients with Parkinson\u2019s disease: A comparison between akineto-rigid and tremor types. J Neurol Sci 103: 232\u2013237","journal-title":"J Neurol Sci"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410330405","volume":"33","author":"WP Gai","year":"1993","unstructured":"Gai WP, Geffen LB, Dehoroy L, et al (1993) Loss of Cl and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson\u2019s disease. Ann Neurol 33: 357\u2013367","journal-title":"Ann Neurol"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jnnp.57.9.1039","volume":"57","author":"WP Gai","year":"1994","unstructured":"Gai WP, Vickers JC, Blumbergs PC, Blessing WW (1994) Loss of nonphosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 57: 1039\u20131046","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/brain\/118.6.1447","volume":"118","author":"WP Gai","year":"1995","unstructured":"Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson\u2019s disease. Brain 118: 1447\u20131459","journal-title":"Brain"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ana.410420410","volume":"42","author":"JE Galvin","year":"1997","unstructured":"Galvin JE, Lee AMY, Baba M, Mann DMA, Dickson DW, Yamaguchi H, Schmidt ML, Iwatsubo T, Trojanowski JQ (1997) Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit. Ann Neurol 42: 595\u2013603","journal-title":"Ann Neurol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00695605","volume":"64","author":"P Gaspar","year":"1984","unstructured":"Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson\u2019s disease. A neuropathological study of 32 cases. Acta Neuropathol 64: 43\u201352","journal-title":"Acta Neuropathol"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ana.410300308","volume":"30","author":"P Gaspar","year":"1991","unstructured":"Gaspar P, Duyckaerts C, Alvarez C et al (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson\u2019s disease. Ann Neurol 30: 365\u2013374","journal-title":"Ann Neurol"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"C Gerfen","year":"1992","unstructured":"Gerfen C (1992) The neostriatal mosaic: Multiple levels of compartmental organization. Trends Neurosci 15: 133\u2013139","journal-title":"Trends Neurosci"},{"key":"1_CR46","first-page":"59","volume-title":"Noradrenergic mechanisms in Parkinson\u2019s disease","author":"M Gerlach","year":"1994","unstructured":"Gerlach M, Jellinger K, Riederer P (1994) The possible role of noradrenergic deficits in selected signs of Parkinson\u2019s disease. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson\u2019s disease. CRC Press, Boca Raton, pp 59\u201371"},{"key":"1_CR47","first-page":"177","volume":"69","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P, Youdim MBH (1996) Molecular mechanisms of neurodegene-ration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids. Adv Neurol 69: 177\u2013194","journal-title":"Adv Neurol"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, White CL (1992) Disease specific patterns of locus ceruleus cell loss. Ann Neurol 32: 667\u2013676","journal-title":"Ann Neurol"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cne.903310302","volume":"331","author":"DC German","year":"1993","unstructured":"German DC, Manaye KE, Sonsalia PK, Brooks BA (1993) Midbrain dopaminergic neurons (nuclei A8, A9, and A10): Three-dimensional reconstruction in the rat. J Comp Neurol 331: 297\u2013309","journal-title":"J Comp Neurol"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ana.410400610","volume":"40","author":"S Gilman","year":"1996","unstructured":"Gilman S, Frey KA, Koeppe RA et al (1996) Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Ann Neurol 40: 885\u2013892","journal-title":"Ann Neurol"},{"key":"1_CR51","first-page":"379","volume-title":"Mineral and metal neurotoxicology","author":"PF Good","year":"1997","unstructured":"Good PF, Olanow CW, Perl DP (1997) LAMMA studies of iron, oxidative stress, and neuroprotective strategies in Parkinson\u2019s disease. In: Yasui M, Strong MJ, Ota K, Veritiy MA (eds) Mineral and metal neurotoxicology. CRC Press, Boca Raton, pp 379\u2013390"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1212\/WNL.47.4.1032","volume":"47","author":"S Goto","year":"1996","unstructured":"Goto S, Matsumoto S, Ushio Y, Hirano A (1996) Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology 47: 1032\u20131036","journal-title":"Neurology"},{"key":"1_CR53","first-page":"17","volume":"53","author":"AM Graybiel","year":"1990","unstructured":"Graybiel AM, Hirsch EC, Agid Y (1990) The nigrostriatal system in Parkinson\u2019s disease. Adv Neurol 53: 17\u201329","journal-title":"Adv Neurol"},{"key":"1_CR54","first-page":"3","volume-title":"Mental dysfunction in Parkinson\u2019s disease","author":"JH Groenewegen","year":"1993","unstructured":"Groenewegen JH, Roeling T, Voorn P, Berendse H (1993) The parallel arrangement of basal ganglia-thalamocortical circuits: a neuronal substrate for the role of dopamine in motor and cognitive functions? In: Wolters EC, Scheltens P (eds) Mental dysfunction in Parkinson\u2019s disease. Vrije Universiteit Amsterdam 193: 3\u201318"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3171\/jns.1997.87.4.0491","volume":"87","author":"C Gross","year":"1997","unstructured":"Gross C, Rougier A, Guehl D et al (1997) High-frequency stimulation of the globus pallidus internalis in Parkinson\u2019s disease \u2014 a study of seven cases. J Neurosurg 87: 491\u2013498","journal-title":"J Neurosurg"},{"key":"1_CR56","first-page":"352","volume":"43","author":"RJ Guiloff","year":"1980","unstructured":"Guiloff RJ, George RJ, Marsden DC (1980) Reversible supranuclear ophthalmoplegia associated with parkinsonism. J Neurol Neurosurg Psychiatry 43: 352\u2013354","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/WNL.48.6.1578","volume":"48","author":"M Guttman","year":"1997","unstructured":"Guttman M, Burkholder J, Kish SJ et al (1997) [C-ll]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson\u2019s disease \u2014 implications for the symptomatic threshold. Neurology 48: 1578\u20131583","journal-title":"Neurology"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/cne.902620109","volume":"262","author":"AE Hallanger","year":"1987","unstructured":"Hallanger AE, Levey AL, Lee HJ et al (1987) The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol 262: 105\u2013124","journal-title":"J Comp Neurol"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"CM Halliday","year":"1990","unstructured":"Halliday CM, Blumbergs PC, Cotton RCH et al (1990a) Loss of brainstem serotonin-and substance P-containing neurons in Parkinson\u2019s disease. Brain Res 510: 104\u2013107","journal-title":"Brain Res"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"CM Halliday","year":"1990","unstructured":"Halliday CM, Blumbergs PC, Cotton RGH et al (1990b) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease. Ann Neurol 27: 373\u2013385","journal-title":"Ann Neurol"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0967-5868(96)90083-1","volume":"3","author":"GM Halliday","year":"1996","unstructured":"Halliday GM, McRitchie DA, Cartwright HR et al (1996) Midbrain neuropathology in idiopathic Parkinson\u2019s disease and diffuse Lewy body disease. J Clin Neurosci 3: 52\u201360","journal-title":"J Clin Neurosci"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/neur.1996.0007","volume":"5","author":"CD Hardman","year":"1996","unstructured":"Hardman CD, McRitchie DA, Halliday GM et al (1996) The substantia nigra pars reticulata in Parkinson\u2019s disease. Neurodegeneration 5: 49\u201355","journal-title":"Neurodegeneration"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/exnr.1997.6415","volume":"144","author":"CD Hardman","year":"1997","unstructured":"Hardman CD, Halliday GM, McRitchie DA et al (1997a) Progressive supranuclear palsy effects both the substantia nigra pars compacta and reticulata. Exp Neurol 144: 183\u2013192","journal-title":"Exp Neurol"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00005072-199702000-00003","volume":"56","author":"CD Hardman","year":"1997","unstructured":"Hardman CD, Halliday GM, McRitchie DA, Morris JGL (1997b) The subthalamic nucleus in Parkinson\u2019s disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 56: 132\u2013142","journal-title":"J Neuropathol Exp Neurol"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0306-4522(94)00422-2","volume":"64","author":"O Heinonen","year":"1995","unstructured":"Heinonen O, Soininen H, Sorvari H et al (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation as an early phenomenon in Alzheimer\u2019s disease. Neuroscience 64: 375\u2013384","journal-title":"Neuroscience"},{"key":"1_CR66","first-page":"954","volume":"39","author":"J Hierholzer","year":"1998","unstructured":"Hierholzer J, Cordes M, Venz S et al (1998) Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes. J Nucl Med 39: 954\u2013960","journal-title":"J Nucl Med"},{"key":"1_CR67","doi-asserted-by":"crossref","unstructured":"Hill WD, Arai M, Cohen JA, et al (1993) Neurofilament mRNA is reduced in Parkinson\u2019s disease substantia nigra pars compacta neurons. J Comp Neurol 328\u2013336","DOI":"10.1002\/cne.903290304"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"EC Hirsch","year":"1987","unstructured":"Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson\u2019s disease and progressive supranuelear palsy. Proc Natl Acad Sci USA 84: 5976\u20135980","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334: 345\u2013348","journal-title":"Nature"},{"key":"1_CR70","first-page":"83","volume":"1","author":"EC Hirsch","year":"1992","unstructured":"Hirsch EC, Mouatt A, Thomasset M et al (1992) Expression of calbindin D (28K) \u2014 like immunoreactivity in catecholaminergic cell groups of the human midbrain; normal distribution and distribution in Parkinson\u2019s disease. Neurodegeneration 1: 83\u201393","journal-title":"Neurodegeneration"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-7091-6842-4_9","volume":"50","author":"EC Hirsch","year":"1997","unstructured":"Hirsch EC, Faucheux B, Damier P et al (1997) Neuronal vulnerability in Parkinson\u2019s disease. J Neural Transm [Suppl] 50: 79\u201388","journal-title":"J Neural Transm [Suppl]"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneur.1997.00550140025008","volume":"54","author":"VA Holthoffdetto","year":"1997","unstructured":"Holthoffdetto VA, Kessler J, Herholz K et al (1997) Functional effects of striatal dysfunction in Parkinson\u2019s disease. Arch Neurol 54: 145\u2013150","journal-title":"Arch Neurol"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/brain\/118.1.131","volume":"118","author":"WJG Hoogendijk","year":"1995","unstructured":"Hoogendijk WJG, Pall CW, Troost D et al (1995) Image analysis-assisted morphometry of the locus ceruleus in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Brain 118: 131\u2013143","journal-title":"Brain"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","volume":"72","author":"S Hunot","year":"1996","unstructured":"Hunot S, Boissiere F, Faucheux B et al (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease. Neuroscience 72: 355\u2013363","journal-title":"Neuroscience"},{"key":"1_CR75","first-page":"326","volume":"68","author":"S Hunter","year":"1985","unstructured":"Hunter S (1985) The rostral mesencephalon in Parkinson\u2019s and Alzheimer\u2019s disease. Acta Neuropathol 68: 326\u2013334","journal-title":"Acta Neuropathol"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/PL00005606","volume":"113","author":"WD Hutchison","year":"1997","unstructured":"Hutchison WD, Lozano AM, Tasker RR et al (1997) Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp Brain Res 113: 557\u2013563","journal-title":"Exp Brain Res"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irrizary","year":"1998","unstructured":"Irrizary MC, Growdon W, Gomez-Isla T et al (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson\u2019s disease and cortical Lewy body disease contain \u03b1-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334\u2013337","journal-title":"J Neuropathol Exp Neurol"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ana.410320410","volume":"32","author":"H Ito","year":"1992","unstructured":"Ito H, Goto S, Sakamoto S, Hirano A (1992) Calbindin-D28K in the basal ganglia of patients with Parkinsonism. Ann Neurol 32: 543\u2013550","journal-title":"Ann Neurol"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1212\/WNL.47.5.1291","volume":"47","author":"H Ito","year":"1996","unstructured":"Ito H, Kosaka H, Matsumoto S, Imai T (1996) Striatal efferent involvement and its correlation to levodopa efficiacy in patients with multiple system atrophy. Neurology 47: 1291\u20131299","journal-title":"Neurology"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mds.870120104","volume":"12","author":"K Itoh","year":"1997","unstructured":"Itoh K, Weis S, Mehraein P, M\u00fcller-H\u00f6cker J (1997) Defects of cytochrome c oxidase in the substantia nigra of Parkinson\u2019s disease: An immunohictochemical and morphometric study. Mov Disord 12: 9\u201316","journal-title":"Mov Disord"},{"key":"1_CR81","first-page":"A323","volume":"48","author":"V Jackson-Lewis","year":"1997","unstructured":"Jackson-Lewis V, Donaldson D, Przedborski S (1997) Apoptosis and Parkinson\u2019s disease (PD). Neurology 48: A323","journal-title":"Neurology"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0306-4522(89)90055-9","volume":"29","author":"F Javoy-Agid","year":"1989","unstructured":"Javoy-Agid F, Scatton B, Ruberg M et al (1989) Distribution of monoaminergic, cholinergic and gabaergic markers in the human cerebral cortex. Neuroscience 29: 251\u2013269","journal-title":"Neuroscience"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","volume":"51","author":"Jellinger","year":"1988","unstructured":"Jellinger (1988) The pedunculopontine nucleus in Parkison\u2019s disease, supranuclear palsy and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 51: 540\u2013544","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-642-73899-9_2","volume-title":"Drugs for the treatment of Parkinson\u2019s disease","author":"K Jellinger","year":"1989","unstructured":"Jellinger K (1989) Pathology of Parkinson\u2019s syndrome. In: Calne DB (ed) Drugs for the treatment of Parkinson\u2019s disease. Springer, Berlin Heidelberg New York Tokyo, pp 47\u2013112"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger KA (1991) Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14: 153\u2013197","journal-title":"Changes other than the nigrostriatal pathway. Mol Chem Neuropathol"},{"key":"1_CR86","first-page":"29","volume":"7","author":"K Jellinger","year":"1993","unstructured":"Jellinger K (1993) Pathogenese und Pathophysiologie der Parkinson-Krankheit. Neuropsychiatrie 7: 29\u201337","journal-title":"Neuropsychiatrie"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/978-3-7091-6563-8_9","volume-title":"Handbuch der Gerontopsychiatrie","author":"KA Jellinger","year":"1996","unstructured":"Jellinger KA (1996) Die Bewegungsst\u00f6rungen im h\u00f6heren Lebensalter. In: Zapotoczky HG, Fischhoff PK (Hrsg) Handbuch der Gerontopsychiatrie. Springer, Wien New York, pp 202\u2013290"},{"key":"1_CR88","first-page":"123","volume":"51","author":"KA Jellinger","year":"1997","unstructured":"Jellinger KA (1997) Morphological substrates of dementia in parkinsonism. A critical update. J Neural Transm [Suppl] 51: 123\u2013147","journal-title":"J Neural Transm [Suppl]"},{"key":"1_CR89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1042-3680(18)30262-6","volume":"9","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Neuropathology of movement disorders. Neurosurg Clin North Am 9: 237\u2013262","journal-title":"Neurosurg Clin North Am"},{"key":"1_CR90","unstructured":"Jellinger KA (1999) Cell death mechanisms in Parkinson\u2019s disease. J Neural Transm (in press)"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1017\/CBO9780511601187.027","volume-title":"Dementia with Lewy bodies","author":"KA Jellinger","year":"1996","unstructured":"Jellinger KA, Bancher C (1996) Dementia with Lewy bodies. Relationship to Parkinson\u2019s and Alzheimer\u2019s disease. In: McKeith LG, Perry E et al (eds) Dementia with Lewy bodies. Cambridge University Press, New York, pp 268\u2013286"},{"issue":"[Suppl3]","key":"1_CR92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","volume":"56","author":"P Jenner","year":"1996","unstructured":"Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson\u2019 disease. Neurology 56 [Suppl 3] pp 161\u2013170","journal-title":"Neurology"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/jnnp.62.2.125","volume":"62","author":"F Johansson","year":"1997","unstructured":"Johansson F, Malm J, Nordh E, Hariz M (1997) Usefulness of pallidotomy in advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62: 125\u2013132","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.870120609","volume":"12","author":"JN Joyce","year":"1997","unstructured":"Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ (1997) Differential modification of dopamin transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson\u2019s, Alzheimer\u2019s with parkinsonism, and Alzheimer\u2019s disease. Mov Disord 12: 885\u2013897","journal-title":"Mov Disord"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1212\/WNL.41.1.25","volume":"41","author":"JL Juncos","year":"1991","unstructured":"Juncos JL, Hirsch EC, Malessa S et al (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41: 25\u201330","journal-title":"Neurology"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-8993(93)91005-D","volume":"606","author":"A Kastner","year":"1993","unstructured":"Kastner A, Hirsch EC, Agid Y, Javoy-Agid F (1993) Tyrosine hydroxylase protein and messenger RNA in the dopaminergic neurons of patients with Parkinson\u2019s disease. Brain Res 606: 341\u2013345","journal-title":"Brain Res"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0022-510X(95)00210-S","volume":"134","author":"E Kienzl","year":"1995","unstructured":"Kienzl E, Puchinger L, Jellinger K et al (1995) The role of transition metals in the pathogenesis of Parkinson\u2019s disease. J Neurol Sci 134 [Suppl]: 69\u201375","journal-title":"J Neurol Sci"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven patterns of dopamine loss in the striatum of patients with Parkinson\u2019s disease. N Engl J Med 318: 876\u2013880","journal-title":"N Engl J Med"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.410420304","volume":"42","author":"W Koller","year":"1997","unstructured":"Koller W, Pahwa R, Busenbark K et al (1997) High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42: 292\u2013299","journal-title":"Ann Neurol"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s004010050590","volume":"93","author":"S K\u00f6sel","year":"1997","unstructured":"K\u00f6sel S, Egensperger R, von Eitzen U et al (1997) On the question of apoptosis in the substantia nigra in Parkinson\u2019s disease. Acta Neuropathol 93: 105\u2013109","journal-title":"Acta Neuropathol"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/archneur.1997.00550200082014","volume":"54","author":"JK Kraus","year":"1997","unstructured":"Kraus JK, Jankovic J, Lai EC et al (1997) Posteroventral medial pallidotomy in Levodopa-unresponsive parkinsonism. Arch Neurol 54: 1026\u20131029","journal-title":"Arch Neurol"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0022-510X(93)90151-N","volume":"117","author":"A Kume","year":"1993","unstructured":"Kume A, Takahashi A, Hashizume Y (1993) Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 117: 33\u201340","journal-title":"J Neurol Sci"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s001090050332","volume":"77","author":"A Kupsch","year":"1998","unstructured":"Kupsch A, Earl C (1998) Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation. J Molec Med 77: 178\u2013184","journal-title":"J Molec Med"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/BF00713525","volume":"83","author":"H Lach","year":"1992","unstructured":"Lach H, Grimes D, Benoit B, Minkiewicz-Janda A (1992) Caudate nucleus pathology in Parkinson\u2019s disease. Ultrastructural and biochemical findings in biopsy material. Acta Neuropathol 83: 352\u2013360","journal-title":"Acta Neuropathol"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cne.903300103","volume":"330","author":"S Lehericy","year":"1993","unstructured":"Lehericy S, Hirsch EC, Pervera-Plerot P et al (1993) Heterogeneity of the degeneration of choliergic neurons in basal forebrain in patients with Alzheimer\u2019s disease. J Comp Neurol 330: 15\u201331","journal-title":"J Comp Neurol"},{"key":"1_CR106","volume-title":"The neurology of eye movement","author":"JR Leigh","year":"1991","unstructured":"Leigh JR, Zee DS (1991) The neurology of eye movement, 2nd edn. FA Davis Philadelphia","edition":"2"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","volume":"339","author":"P Limousin","year":"1998","unstructured":"Limousin P, Krack P, Pollak P et al (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. New Engl J Med 339: 1105\u20131111","journal-title":"New Engl J Med"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0925-4439(96)00020-8","volume":"1316","author":"W Linert","year":"1996","unstructured":"Linert W, Herlinger E, Jameson RF et al (1996) Dopamine, 6-hydroxydopamine, iron, and dioxygen \u2014 their mutual interactions and possible implication in the development of Parkinson\u2019s disease. Biochem Biophys Acta 1316: 160\u2013168","journal-title":"Biochem Biophys Acta"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","volume":"55","author":"I Litvan","year":"1996","unstructured":"Litvan I, Hauw JJ, Bartko JJ et al (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97\u2013105","journal-title":"J Neuropathol Exp Neurol"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0306-4522(86)90155-7","volume":"18","author":"SE Loughlin","year":"1986","unstructured":"Loughlin SE, Foote SL, Bloom FE (1986) Efferent projections of nucleus locus coeruleus: Topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience 18: 291\u2013306","journal-title":"Neuroscience"},{"key":"1_CR111","first-page":"280","volume-title":"Greenfield\u2019s neuropathology","author":"J Lowe","year":"1997","unstructured":"Lowe J, Lennox G, Leigh PN (1997) Disorders of movement and system degenerations. In: Graham DI, Lantos PL (eds) Greenfield\u2019s neuropathology, 6th edn. E Arnold, London, pp 280\u2013366","edition":"6"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/cne.903450407","volume":"345","author":"E Lynd-Balta","year":"1994","unstructured":"Lynd-Balta E, Haber SN (1994) Primate striatonigral projections: A comparison of the sensorimotor-related striatum and the ventral striatum. J Comp Neurol 345: 562\u2013578","journal-title":"J Comp Neurol"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0022-510X(96)00069-X","volume":"140","author":"SY Ma","year":"1996","unstructured":"Ma SY, Rinne JO, Collan Y et al (1996) A quantitative morphometrical study of the neuron degeneration in the substantia nigra in patients with Parkinson\u2019s disease. J Neurol Sci 140: 40\u201345","journal-title":"J Neurol Sci"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-510X(97)00100-7","volume":"151","author":"SY Ma","year":"1997","unstructured":"Ma SY, R\u00f6ytt\u00e4 M, Rinne JO et al (1997) Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson\u2019s disease using disector counts. J Neurol Sci 151: 83\u201387","journal-title":"J Neurol Sci"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.40.11.1739","volume":"40","author":"S Malessa","year":"1990","unstructured":"Malessa S, Hirsch EC, Cerver P et al (1990) Catecholaminergic systems in the medulla obiongata in Parkinsonian syndromes. A quantitative immunohistochemical study in Parkinson\u2019s disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology 40: 1739\u20131742","journal-title":"Neurology"},{"key":"1_CR116","first-page":"1","volume":"2","author":"DMA Mann","year":"1983","unstructured":"Mann DMA, Yates PO, Hawkes J (1983) The pathology of the human locus coeruleus. Clin Neuropathol 2: 1\u20137","journal-title":"Clin Neuropathol"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1212\/WNL.46.1.231","volume":"46","author":"KL Marek","year":"1996","unstructured":"Marek KL, Seibyl JP, Zoghbi SS et al (1996) (123I)\u03b2-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson\u2019s disease. Neurology 46: 231\u2013237","journal-title":"Neurology"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02252963","volume":"9","author":"RM Marie","year":"1995","unstructured":"Marie RM, Barre L, Rioux P et al (1995) PET imaging of neocortical monoaminergic terminals in Parkinson\u2019s disease. J Neural Transm (PD-Dem Sect) 9: 55\u201371","journal-title":"J Neural Transm (PD-Dem Sect)"},{"key":"1_CR119","first-page":"505","volume":"10","author":"E Masliah","year":"1995","unstructured":"Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer\u2019s disease. Histol Histopathol 10: 505\u2013519","journal-title":"Histol Histopathol"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ana.410180507","volume":"18","author":"MM Matzuk","year":"1985","unstructured":"Matzuk MM, Saper CB (1985) Preservation of hypothalamic dopaminergic neurons in Parkinson\u2019s disease. Ann Neurol 18: 552\u2013555","journal-title":"Ann Neurol"},{"key":"1_CR121","first-page":"112","volume-title":"Drugs for the treatment of Parkinson\u2019s disease. Handbook of experimental pharmacology","author":"EG McGeer","year":"1989","unstructured":"McGeer EG, McGeer PL (1989) Biochemical neuroanatomy of the basal ganglia. In: Calne DB (ed) Drugs for the treatment of Parkinson\u2019s disease. Handbook of experimental pharmacology, vol 88. Springer, Wien-New York, pp 112\u2013148"},{"key":"1_CR122","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonisrn indicates active neuropathological process. Ann Neurol 24: 574\u2013576","journal-title":"Ann Neurol"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/exnr.1997.6418","volume":"144","author":"DA McRitchie","year":"1997","unstructured":"McRitchie DA, Cartwright HR, Halliday GM (1997) Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson\u2019s disease. Exp Neurol 144: 202\u2013213","journal-title":"Exp Neurol"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.410410417","volume":"41","author":"GW Miller","year":"1997","unstructured":"Miller GW, Staley JK, Heilman CJ et al (1997) Immunochemical analysis of dopamine transporter protein in Parkinson\u2019s disease. Ann Neurol 41: 530\u2013539","journal-title":"Ann Neurol"},{"key":"1_CR125","first-page":"94","volume-title":"Function and dysfunction in the basal ganglia","author":"IJ Mitchell","year":"1990","unstructured":"Mitchell IJ, Aambrook MA, Jackson A et al (1990) Basal ganglia function in experimental movement disorders. In: Franks AJ (ed) Function and dysfunction in the basal ganglia. Manchester University Press, Manchester, NY, pp 94\u2013109"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-7091-6842-4_13","volume":"50","author":"H Mochizuki","year":"1997","unstructured":"Mochizuki H, Mori H, Mizuno Y (1997) Apoptosis in neurodegenerative disorders. J Neural Transm [Suppl] 50: 125\u2013140","journal-title":"J Neural Transm [Suppl]"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archneur.55.3.372","volume":"55","author":"D Monza","year":"1998","unstructured":"Monza D, Soliveri P, Radice V et al (1998) Cognitive dysfunction and impaired organization of complex motility in degenerative Parkinsonian syndromes. Arch Neurol 55: 372\u2013378","journal-title":"Arch Neurol"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/brain\/119.6.2097","volume":"119","author":"PK Morrish","year":"1996","unstructured":"Morrish PK, Sawle GV, Brooks DJ (1996) Regional changes in [18F]dopa metabolism in the striatum in Parkinson\u2019s disease. Brain 119: 2097\u20132103","journal-title":"Brain"},{"key":"1_CR129","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/00001756-199505090-00028","volume":"6","author":"EJ Mufson","year":"1995","unstructured":"Mufson EJ, Conner JM, Kordower JH (1995) Nerve growth factor in Alzheimer\u2019s disease. Defective retrograde transport to nucleus basalis. Neuroreport 6: 1063\u20131066","journal-title":"Neuroreport"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0006-8993(88)90124-2","volume":"455","author":"TH Neill","year":"1988","unstructured":"Neill TH, Brown SA, Rafols JA, Shoulson L (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson\u2019s disease. Brain Res 455: 148\u2013152","journal-title":"Brain Res"},{"key":"1_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-10343-2","volume-title":"The human central nervous system. A synopsis and atlas","author":"R Nieuwenhuys","year":"1988","unstructured":"Nieuwenhuys R, Voogel J, Van Huizen C (1988) The human central nervous system. A synopsis and atlas, 3rd edn. Springer, Berlin Heidelberg New York Tokyo.","edition":"3"},{"key":"1_CR132","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","volume":"16","author":"MJ Nirenberg","year":"1996","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR et al (1996) The dopamin transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16: 436\u2013447","journal-title":"J Neurosci"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0006-8993(94)91940-2","volume":"634","author":"M Nishimura","year":"1994","unstructured":"Nishimura M, Tomimoto H, Suenaga T, et al (1994) Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson\u2019s disease brains. Brain Res 634: 339\u2013344","journal-title":"Brain Res"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1097\/00001756-199808240-00030","volume":"9","author":"T Nishio","year":"1998","unstructured":"Nishio T, Furukawa S, Akiguchi I, Sunohara N (1998) Medial nigral dopamine neurons have rich neurotrophin support. NeuroReport 9: 2847\u20132851","journal-title":"NeuroReport"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/jnnp.62.1.2","volume":"62","author":"JA Obeso","year":"1997","unstructured":"Obeso JA, Guridi J, DeLong M (1997) Surgery for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62: 2\u20138","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR136","first-page":"452","volume":"44","author":"CW Olanow","year":"1998","unstructured":"Olanow CW, Tatton N, Redman R, Perl D, Walker R, Tatton WG (1998) Apoptosis and mitochondrial potential in Parkinson\u2019s disease (abstract). Ann Neurol 44: 452","journal-title":"Ann Neurol"},{"key":"1_CR137","volume-title":"Cytoarchitecture of the human brain stem","author":"J Olszewski","year":"1982","unstructured":"Olszewski J, Baxter D (1982) Cytoarchitecture of the human brain stem 2nd edn. Karger, Basel","edition":"2"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1212\/WNL.51.4.1063","volume":"51","author":"W Ondo","year":"1998","unstructured":"Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK (1998) Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson\u2019s disease tremor. Neurology 51: 1063\u20131069","journal-title":"Neurology"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0022-510X(95)00316-T","volume":"136","author":"M Otsuka","year":"1996","unstructured":"Otsuka M, Ichiya Y, Kuwabara Y et al (1996) Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson\u2019s disease: correlation with the three main symptoms. J Neurol Sci 136: 169\u2013173","journal-title":"J Neurol Sci"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1046\/j.1468-1331.1998.550431.x","volume":"5","author":"R Pahwa","year":"1998","unstructured":"Pahwa R, Paolo A, Tr\u00f6ster A, Koller W (1998) Cognitive impairment in Parkinson\u2019s disease. Eur J Neurol 5: 431\u2013441","journal-title":"Eur J Neurol"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","volume":"54","author":"B Pakkenberg","year":"1991","unstructured":"Pakkenberg B, Moller A, Gundersen HJG et al (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson\u2019s disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54: 30\u201333","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati L-N (1995) Functional anatomy of the basal ganglia. I. The cortico-basal-ganglia-thalamo-corticol loop. Brain Res Rev 20: 91\u2013127","journal-title":"Brain Res Rev"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subtypes of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50: 143\u2013155","journal-title":"J Neuropathol Exp Neurol"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4613-0485-2_1","volume-title":"The basal ganglia, Vol IV, New ideas and data on structure and function","author":"G Percheron","year":"1994","unstructured":"Percheron G, Francois C, Yelnik J et al (1994) The basal ganglia related system of primates: Definition, description and informational analysis. In: Percheron G, McKensie JS, F\u00e9ger J (eds) The basal ganglia, Vol IV, New ideas and data on structure and function. Plenum Press, New York, pp 3\u201320"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00002093-199307020-00002","volume":"7","author":"EK Perry","year":"1993","unstructured":"Perry EK, Irving D, Kerwin JM et al (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson\u2019s and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 7: 69\u201379","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1_CR146","first-page":"265","volume-title":"Dementia in Parkinson\u2019s disease","author":"B Pillon","year":"1994","unstructured":"Pillon B, Deweer B, Malapani C et al (1994) Explicit memory disorders of demented parkinsonian patients and underlying neuronal basis. In: Korczyn AD (ed) Dementia in Parkinson\u2019s disease. Monduzzi, Bologna, pp 265\u2013271"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"MS Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183\u2013191","journal-title":"J Neuropathol Exp Neurol"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/brain\/112.5.1193","volume":"112","author":"O Rascol","year":"1989","unstructured":"Rascol O, Clanet M, Motastruc JL et al (1989) Abnormal ocular movements in Parkinson\u2019s disease. Brain 112: 1193\u20131214","journal-title":"Brain"},{"key":"1_CR149","first-page":"114","volume":"3","author":"WJG Reid","year":"1992","unstructured":"Reid WJG, Broe, GA, Morris JGL (1992) The roile of cholinergic deficiency in neuropsychological deficits in idiopathic Parkinson\u2019s disease. Dementia 3: 114\u2013120","journal-title":"Dementia"},{"key":"1_CR150","first-page":"121","volume":"14","author":"P Riederer","year":"1978","unstructured":"Riederer P, Rausch WD, Birkmayer W et al (1978) CNS modulation of adrenal tyrosine hydroxylase in Parkinson\u2019s disease and metabolic encephalopathies. J Neural Transm [Suppl] 14: 121\u2013133","journal-title":"J Neural Transm [Suppl]"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.410260107","volume":"26","author":"JO Rinne","year":"1989","unstructured":"Rinne JO, Rummukainen J, Palj\u00e4rvi J, Rinne UK (1989) Dementia in Parkinson\u2019s disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26: 47\u201350","journal-title":"Ann Neurol"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ana.410370505","volume":"37","author":"JO Rinne","year":"1995","unstructured":"Rinne JO, Burn DJ, Mathias CJ et al (1995a) Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol 37: 568\u2013573","journal-title":"Ann Neurol"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0022-510X(95)00137-Q","volume":"132","author":"JO Rinne","year":"1995","unstructured":"Rinne JO, Leihinnen A, Ruottinen H et al (1995b) Increased densitiy of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson\u2019s disease \u2014 A PET study with [C-ll]raclopride. J Neurol Sci 132: 156\u2013161","journal-title":"J Neurol Sci"},{"key":"1_CR154","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1353-8020(96)00046-6","volume":"3","author":"JO Rinne","year":"1997","unstructured":"Rinne JO, Kuikka JT, Berstr\u00f6m MA et al (1997) Striatal dopamine transporter in Parkinson\u2019s disease; a study with a new radioligand, (123I)B-CIT-FP. Parkinsonism Rel Disord 3: 77\u201381","journal-title":"Parkinsonism Rel Disord"},{"key":"1_CR155","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0166-2236(92)90034-6","volume":"15","author":"H Robertson","year":"1992","unstructured":"Robertson H (1992) Dopamine receptor interactions: Some implications for the treatment of Parkinson\u2019s disease. Trends Neurosci 15: 201\u2013206","journal-title":"Trends Neurosci"},{"key":"1_CR156","first-page":"157","volume-title":"Handbook of psychopharmacology, vol 20, Psychopharmacology of aging nervous system","author":"M Ruberg","year":"1988","unstructured":"Ruberg M, Agid Y (1988) Dementia in Parkinson\u2019s disease. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 20, Psychopharmacology of aging nervous system. Plenum Press, New York, pp 157\u2013206"},{"key":"1_CR157","first-page":"1089","volume":"35","author":"CD Saper","year":"1985","unstructured":"Saper CD, German DC, White CL (1985) Neuronal pathology in the nucleus basalis of Meynert and associated cell groups in senile dementia of the Alzheimer\u2019s type. Possible role of cell loss. Neurology 35: 1089\u20131095","journal-title":"Possible role of cell loss. Neurology"},{"key":"1_CR158","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1126\/science.1825731","volume":"251","author":"T Sawaguchi","year":"1991","unstructured":"Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 247\u2013250","journal-title":"Science"},{"key":"1_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-3940(87)90664-1","volume":"79","author":"E Scarnati","year":"1987","unstructured":"Scarnati E, Casbarri A, Campana E, Pacitti C (1987) The organization ot the nucleus tegmenti pedunculopontine neurons projecting to basal ganglia and thalamus. Neurosci Lett 79: 11\u201316","journal-title":"Neurosci Lett"},{"key":"1_CR160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.1995.tb01022.x","volume":"21","author":"AHV Schapira","year":"1995","unstructured":"Schapira AHV (1995) Oxidative stress in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 21: 3\u20139","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1_CR161","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0306-4522(90)90440-F","volume":"36","author":"KS Sims","year":"1990","unstructured":"Sims KS, Williams RS (1990) The human amygdaloid complex. Neuroscience 36: 449\u2013472","journal-title":"Neuroscience"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-synuclein in Lewy bodies. Nature 388: 839\u2013840","journal-title":"Nature"},{"key":"1_CR163","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R et al (1998) \u03b1-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95: 6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR164","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198542667.001.0001","volume-title":"Brain cholinergic systems","author":"M Steriade","year":"1990","unstructured":"Steriade M, Biesold D (1990) Brain cholinergic systems. Oxford University Press, Oxford"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00019052-199808000-00008","volume":"11","author":"AJ Stoessl","year":"1998","unstructured":"Stoessl AJ, Ruth TJ (1998) Neuroreceptor imaging: new developments om PET and SPECT imaging of neuroreceptor binding (including dopamine transporters, vesicle transporters and post synaptic receptor sites). Curr Opin Neurol 11: 327\u2013333","journal-title":"Curr Opin Neurol"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.870120517","volume":"12","author":"A Strafella","year":"1997","unstructured":"Strafella A, Ashby P, Munz M et al (1997) Inhibition of voluntary activity by thalamic stimulation in humans \u2014 relevance for the control of tremor. Mov Disord 12: 727\u2013737","journal-title":"Mov Disord"},{"key":"1_CR167","doi-asserted-by":"publisher","first-page":"14245","DOI":"10.1074\/jbc.271.24.14245","volume":"271","author":"D Sun","year":"1996","unstructured":"Sun D, Leung CL, Liem RKH (1996) Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk5 and p53. J Biol Chem 271: 14245\u201314251","journal-title":"J Biol Chem"},{"key":"1_CR168","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0404.1984.tb07775.x","volume":"69","author":"F Tagliavini","year":"1984","unstructured":"Tagliavini F, Pilleri G, Bouras C, Constantinidis J (1984) The basal nucleus of Meynert in idiopathic parkinson\u2019s disease. Acta Neurol Scand 69: 20\u201328","journal-title":"Acta Neurol Scand"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3171\/jns.1997.86.4.0642","volume":"86","author":"JM Taha","year":"1997","unstructured":"Taha JM, Favre J, Baumann TK, Burchiel KJ (1997) Tremor control after pallidotomy in patients with Parkinson\u2019s disease \u2014 correlation with microrecording findings. J Neurosurg 86: 642\u2013647","journal-title":"J Neurosurg"},{"key":"1_CR170","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/exnr.1996.6385","volume":"144","author":"RR Tasker","year":"1997","unstructured":"Tasker RR, Lang AE, Lozano AM (1997) Pallidal and thalamic surgery for Parkinson\u2019s disease. Exp Neurol 144: 35\u201340","journal-title":"Exp Neurol"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-7091-6842-4_4","volume":"50","author":"G Tissingh","year":"1997","unstructured":"Tissingh G, Booij J, Winogrodzka A et al (1997) IBZM-and CIT-SPECT of the dopaminergic system in parkinsonism. J Neurol Transm [Suppl] 50: 31\u201337","journal-title":"J Neurol Transm [Suppl]"},{"key":"1_CR172","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s004150050168","volume":"245","author":"G Tissingh","year":"1998","unstructured":"Tissingh G, Bergmans P, Booij J et al (1998) Drug-naive patients with Parkinson\u2019s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [1-123]\u03b2-cit spect. J Neurol 245: 14\u201320","journal-title":"J Neurol"},{"key":"1_CR173","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0006-8993(97)00874-3","volume":"775","author":"MM Tompkins","year":"1997","unstructured":"Tompkins MM, Hill WD (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res 775: 24\u201329","journal-title":"Brain Res"},{"key":"1_CR174","first-page":"119","volume":"150","author":"MM Tompkins","year":"1997","unstructured":"Tompkins MM, Basgall EJ, Zamrini E, Hill WD (1997) Apoptotic-like changes in Lewy body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 150: 119\u2013131","journal-title":"Am J Pathol"},{"key":"1_CR175","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1749-6632.1994.tb44403.x","volume":"747","author":"JQ Trojanowski","year":"1994","unstructured":"Trojanowski JQ, Lee VM-Y (1994) Phosphorylation of neuronal cytoskeletal proteins in Alzheimer\u2019s disease and Lewy body dementia. Ann NY Acad Sci 747: 92\u2013109","journal-title":"Ann NY Acad Sci"},{"key":"1_CR176","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archneur.55.2.151","volume":"55","author":"JQ Trojanowski","year":"1998","unstructured":"Trojanowski JQ, Lee VMY (1998) Aggregation of neurofilament and \u03b1-synuclein proteins in Lewy bodies \u2014 Implications for the pathogenesis of Parkinson\u2019s disease and Lewy body dementia. Arch Neurol 55: 151\u2013152","journal-title":"Arch Neurol"},{"key":"1_CR177","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1212\/WNL.49.3.717","volume":"49","author":"N Turjanski","year":"1997","unstructured":"Turjanski N, Lees AJ, Brooks DJ (1997) In vivo studies on striatal dopamine D1 and D2 site binding in 1-dopa treated Parkinson\u2019s disease patients with and without dyskinesias. Neurology 49: 717\u2013723","journal-title":"Neurology"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ana.410430503","volume":"43","author":"GR Uhl","year":"1998","unstructured":"Uhl GR (1998) Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson\u2019s disease. Ann Neurol 43: 555\u2013560","journal-title":"Ann Neurol"},{"key":"1_CR179","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.410350421","volume":"35","author":"GR Uhl","year":"1994","unstructured":"Uhl GR, Walther D, Mash D et al (1994) Dopamine transporter messenger RNA in Parkinson\u2019s disease and control substantia nigra neurons. Ann Neurol 35: 494\u2013498","journal-title":"Ann Neurol"},{"key":"1_CR180","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0306-4522(94)90006-X","volume":"63","author":"M Varastet","year":"1994","unstructured":"Varastet M, Riche D, Maziere M, Hantraye P (1994) Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons in Parkinson\u2019s disease. Neuroscience 63: 47\u201356","journal-title":"Neuroscience"},{"key":"1_CR181","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0197-4580(94)90143-0","volume":"15","author":"T Vereecken","year":"1994","unstructured":"Vereecken ThHLG, Vogels OJM, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer\u2019s disease. Neurobiol Aging 15: 45\u201354","journal-title":"Neurobiol Aging"},{"key":"1_CR182","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1212\/WNL.46.3.802","volume":"46","author":"M Vila","year":"1996","unstructured":"Vila M, Herrero MT, Levy R et al (1996) Consequences of nigrostriatal denervation on the Y-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46: 502\u2013509","journal-title":"Neurology"},{"key":"1_CR183","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S et al (1988) Parkinson\u2019s disease: The presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol 76: 217\u2013221","journal-title":"Acta Neuropathol"},{"key":"1_CR184","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1212\/WNL.46.3.747","volume":"46","author":"AJ Wills","year":"1996","unstructured":"Wills AJ, Thompson PD, Findley LJ, Brooks DJ (1996) A positron emission tomography study of primary orthostatic tremor. Neurology 46: 747\u2013752","journal-title":"Neurology"},{"key":"1_CR185","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-510X(90)90155-G","volume":"99","author":"JH Xuereb","year":"1990","unstructured":"Xuereb JH, Perry EK, Candy JM et al (1990) Parameters of cholinergic neurotransmission in the thalamus in Parkinson\u2019s disease and Alzheimer\u2019s disease. J Neurol Sci 99: 185\u2013197","journal-title":"J Neurol Sci"},{"key":"1_CR186","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1460-9568.1996.tb01573.x","volume":"8","author":"KKL Yung","year":"1996","unstructured":"Yung KKL, Smith AD, Levey AL, Bolam JP (1996) Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat \u2014 Evidence from dopamine receptor and neuropeptide immunostaining. Eur J Neurosci 8: 861\u2013869","journal-title":"Eur J Neurosci"},{"key":"1_CR187","first-page":"72","volume":"6","author":"GS Zubenko","year":"1992","unstructured":"Zubenko GS (1992) Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 6: 72\u201393","journal-title":"Neuropsychopharmacology"},{"key":"1_CR188","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archneur.1990.00530020117023","volume":"47","author":"GS Zubenko","year":"1990","unstructured":"Zubenko GS, Moossy J, Kopp U (1990) Neurochemical correlates of major depression in primary dementia. Arch Neurol 47: 209\u2013214","journal-title":"Arch Neurol"},{"key":"1_CR189","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.410260106","volume":"26","author":"RM Zweig","year":"1989","unstructured":"Zweig RM, Jankel WR, Hedreen JC et al (1989a) The pedunculopontine nucleus in Parkinson\u2019s disease. Ann Neurol 26: 41\u201346","journal-title":"Ann Neurol"},{"key":"1_CR190","first-page":"353","volume-title":"Alzheimer\u2019s disease and related disorders","author":"RM Zweig","year":"1989","unstructured":"Zweig RM, Ross CA, Hedreen JC et al (1989b) Neuropathology of aminergic nuclei in Alzheimer\u2019s disease. In: Iqbal K, Wisniewski HM (eds) Alzheimer\u2019s disease and related disorders. Liss, New York, pp 353\u2013365"},{"key":"1_CR191","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1212\/WNL.43.5.986","volume":"43","author":"RM Zweig","year":"1993","unstructured":"Zweig RM, Cardilio JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson\u2019s disease. Neurology 43: 986\u2013991","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission. Supplementa","Diagnosis and Treatment of Parkinson\u2019s Disease \u2014 State of the Art"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6360-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T01:59:50Z","timestamp":1714442390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6360-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9783211832752","9783709163603"],"references-count":191,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6360-3_1","relation":{},"ISSN":["0303-6995"],"issn-type":[{"value":"0303-6995","type":"print"}],"subject":[],"published":{"date-parts":[[1999]]}}}